Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ResApp Health Limited
  6. News
  7. Summary
    RAP   AU000000RAP5

RESAPP HEALTH LIMITED

(RAP)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Resapp Health : Secures Regulatory Clearance in Australia for Wearable Medical Device; Shares Jump 3%

03/24/2021 | 09:44pm EDT


ę MT Newswires 2021
All news about RESAPP HEALTH LIMITED
08/03RESAPP HEALTH : Jumps 23% After Securing Two Licensing Agreements for Smartphone..
MT
08/03RESAPP HEALTH : Alodokter to launch ResAppDx in Indonesia
PU
08/03RESAPP HEALTH : Medgate enters licence agreement with ResApp Health
PU
07/05RESAPP HEALTH : Commercial agreement with Doctors on Demand in Australia
PU
07/04Resapp Health Limited Signs A Commercial Agreement with Australian-Based Tele..
CI
06/03RESAPP HEALTH : Medgate extends European ResAppDx trial
PU
06/02Medgate Extends European ResAppDx Trial
CI
05/17RESAPP HEALTH : Recruits First Participant in COVID-19 Study; Shares Jump 6%
MT
05/16ResApp Health Limited Reports Recruited the First Participant in Its US-Based..
CI
05/04RESAPP HEALTH : Signs Distribution Deal for Smartphone Diagnostic App in Kenya; ..
MT
More news
Financials
Sales 2020 - - -
Net income 2020 -8,47 M -6,28 M -6,28 M
Net cash 2020 5,45 M 4,04 M 4,04 M
P/E ratio 2020 -14,6x
Yield 2020 -
Capitalization 34,4 M 25,4 M 25,5 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 500
Free-Float 95,7%
Chart RESAPP HEALTH LIMITED
Duration : Period :
ResApp Health Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESAPP HEALTH LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Last Close Price 0,04 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Tony Keating Chief Executive Officer, Executive Director & MD
Roger Aston Non-Executive Chairman
Udantha Abeyratne Chief Scientist
Rob Keniger Vice President-Technology
Christopher Ntoumenopoulos Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
RESAPP HEALTH LIMITED-52.94%25
ORACLE CORPORATION38.72%250 554
SAP SE13.69%170 469
INTUIT INC.38.87%144 877
SERVICENOW, INC.6.22%115 842
DOCUSIGN, INC.31.65%57 020